292 related articles for article (PubMed ID: 24168461)
21. Fabrication of Low-Generation Dendrimers into Nanostructures for Efficient and Nontoxic Gene Delivery.
Wang H; Chang H; Zhang Q; Cheng Y
Top Curr Chem (Cham); 2017 Jun; 375(3):62. PubMed ID: 28555280
[TBL] [Abstract][Full Text] [Related]
22. Improving gene delivery efficiency of bioreducible poly(amidoamine)s via grafting with dendritic poly(amidoamine)s.
Xue YN; Liu M; Peng L; Huang SW; Zhuo RX
Macromol Biosci; 2010 Apr; 10(4):404-14. PubMed ID: 20020519
[TBL] [Abstract][Full Text] [Related]
23. Poly-glutamic dendrimer-based conjugates for cancer vaccination - a computational design for targeted delivery of antigens.
Moura LIF; Martinho N; Silva LC; Barata TS; Brocchini S; Florindo HF; Zloh M
J Drug Target; 2017; 25(9-10):873-880. PubMed ID: 28795601
[TBL] [Abstract][Full Text] [Related]
24. Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: a concise overview.
Mignani S; El Kazzouli S; Bousmina M; Majoral JP
Adv Drug Deliv Rev; 2013 Oct; 65(10):1316-30. PubMed ID: 23415951
[TBL] [Abstract][Full Text] [Related]
25. Receptor-mediated gene delivery using PAMAM dendrimers conjugated with peptides recognized by mesenchymal stem cells.
Santos JL; Pandita D; Rodrigues J; Pêgo AP; Granja PL; Balian G; Tomás H
Mol Pharm; 2010 Jun; 7(3):763-74. PubMed ID: 20230026
[TBL] [Abstract][Full Text] [Related]
26. Cationic Materials for Gene Therapy: A Look Back to the Birth and Development of 2,2-Bis-(hydroxymethyl)Propanoic Acid-Based Dendrimer Scaffolds.
Alfei S
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958989
[TBL] [Abstract][Full Text] [Related]
27. 2-Aminoimidazole facilitates efficient gene delivery in a low molecular weight poly(amidoamine) dendrimer.
Wang J; Hu X; Wang D; Xie C; Lu W; Song J; Wang R; Gao C; Liu M
Org Biomol Chem; 2018 Jun; 16(24):4464-4470. PubMed ID: 29850756
[TBL] [Abstract][Full Text] [Related]
28. Gene delivery using functional dendritic polymers.
Paleos CM; Tziveleka LA; Sideratou Z; Tsiourvas D
Expert Opin Drug Deliv; 2009 Jan; 6(1):27-38. PubMed ID: 19236206
[TBL] [Abstract][Full Text] [Related]
29. Evaluating the gene-expression profiles of HeLa cancer cells treated with activated and nonactivated poly(amidoamine) dendrimers, and their DNA complexes.
Kuo JH; Liou MJ; Chiu HC
Mol Pharm; 2010 Jun; 7(3):805-14. PubMed ID: 20394435
[TBL] [Abstract][Full Text] [Related]
30. Multifunctional lactobionic acid-modified dendrimers for targeted drug delivery to liver cancer cells: investigating the role played by PEG spacer.
Fu F; Wu Y; Zhu J; Wen S; Shen M; Shi X
ACS Appl Mater Interfaces; 2014 Sep; 6(18):16416-25. PubMed ID: 25185074
[TBL] [Abstract][Full Text] [Related]
31. Poly(amido amine) dendrimers in oral delivery.
Yellepeddi VK; Ghandehari H
Tissue Barriers; 2016; 4(2):e1173773. PubMed ID: 27358755
[TBL] [Abstract][Full Text] [Related]
32. Delivering siRNA with Dendrimers: In Vivo Applications.
Leiro V; Santos SD; Pego AP
Curr Gene Ther; 2017; 17(2):105-119. PubMed ID: 28494741
[TBL] [Abstract][Full Text] [Related]
33. Tailoring the dendrimer core for efficient gene delivery.
Hu J; Hu K; Cheng Y
Acta Biomater; 2016 Apr; 35():1-11. PubMed ID: 26923528
[TBL] [Abstract][Full Text] [Related]
34. How to study dendrimers and dendriplexes III. Biodistribution, pharmacokinetics and toxicity in vivo.
Shcharbin D; Janaszewska A; Klajnert-Maculewicz B; Ziemba B; Dzmitruk V; Halets I; Loznikova S; Shcharbina N; Milowska K; Ionov M; Shakhbazau A; Bryszewska M
J Control Release; 2014 May; 181():40-52. PubMed ID: 24607663
[TBL] [Abstract][Full Text] [Related]
35. Polyamidoamine (PAMAM) dendrimers modified with short oligopeptides for early endosomal escape and enhanced gene delivery.
Thuy le T; Mallick S; Choi JS
Int J Pharm; 2015 Aug; 492(1-2):233-43. PubMed ID: 26187169
[TBL] [Abstract][Full Text] [Related]
36. Dendrosome-dendriplex inside liposomes: as a gene delivery system.
Movassaghian S; Moghimi HR; Shirazi FH; Torchilin VP
J Drug Target; 2011 Dec; 19(10):925-32. PubMed ID: 22023509
[TBL] [Abstract][Full Text] [Related]
37. Disulfide cross-linked low generation dendrimers with high gene transfection efficacy, low cytotoxicity, and low cost.
Liu H; Wang H; Yang W; Cheng Y
J Am Chem Soc; 2012 Oct; 134(42):17680-7. PubMed ID: 23050493
[TBL] [Abstract][Full Text] [Related]
38. Dendrimers as vectors for genetic material delivery to the nervous system.
Pérez-Martínez FC; Ocaña AV; Pérez-Carrión MD; Ceña V
Curr Med Chem; 2012; 19(29):5101-8. PubMed ID: 22963638
[TBL] [Abstract][Full Text] [Related]
39. Dendrimers as Non-Viral Vectors in Gene-Directed Enzyme Prodrug Therapy.
Chis AA; Dobrea CM; Rus LL; Frum A; Morgovan C; Butuca A; Totan M; Juncan AM; Gligor FG; Arseniu AM
Molecules; 2021 Oct; 26(19):. PubMed ID: 34641519
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of oral therapeutics delivered by dendrimer-based carriers.
Yellepeddi VK; Ghandehari H
Expert Opin Drug Deliv; 2019 Oct; 16(10):1051-1061. PubMed ID: 31414922
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
